Displaying items by tag: division of infectious diseases

Many people who are immunocompromised will not fully develop the appropriate antibodies after COVID-19 vaccination, but there is hope in the form of an alternative treatment.
The monoclonal antibody cocktail is deliverable via a nasal dose, and it is also effective against SARS, MERS and several coronavirus cold viruses. The antibodies are engineered for long-acting effectiveness, potentially lasting a year or more when used in humans.
UAB infectious disease specialist Molly Fleece, M.D., says that, if you ever had chickenpox, you could get shingles.
Researchers hope to learn whether the immune system will respond to the experimental vaccines by making antibodies and T cells that could fight HIV if a person is ever exposed to the virus in the future.
UAB infectious diseases expert will discuss mask fit, filtration and effectiveness during the coronavirus pandemic in a free webinar Feb. 17 from noon-1 p.m.

UAB’s Know Overdose Initiative seeks to educate, identify and prescribe Naloxone for individuals who have been identified as high risk for overdose.

Many Americans are catching up on missed holiday plans, but should you go ahead and receive your booster shot to ensure the safety of yourself and others?

Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.
Tagged under
Page 1 of 11